DNA methylation as a promising landscape: A simple blood test for breast cancer prediction.
Tehrān, Iran. In Tumour Biol, Jul 2015
WBC's DNA was the focus of several case-control studies at both genome wide and candidate gene levels to reveal epigenetic changes accounting for predisposition to breast cancer, leading to suggest that ATM, TITF1, SFRP1, NUP155, NEUROD1, ZNF217, DBC2, DOK7 and ESR1 genes and the LINE1, Alu and Sat2 DNA elements could be considered as the potential epimarkers.
Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives.
Suita, Japan. In Cancer Cell Int, 2014
In particular, we focus on the mechanism of platinum resistance in clear cell carcinoma, including the role of annexin A4, one of the most investigated factors of platinum resistance, as well as the mutant genes and overexpressed proteins such as VEGF, PI3K/AKT/mTOR signaling pathway, ARID1A, hepatocyte nuclear factor-1β, ZNF217.
In situ analyses of genome instability in breast cancer.
San Francisco, United States. In Nat Genet, 2004
We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization.